Patent · US Expired

1,2,4-triazolo4,3-b!pyridazine derivatives and their use

US5905079A · kind A · utility

21Cited by
4References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 7, 1997
Grant dateMay 18, 1999
Priority date
Expiry dateOct 7, 2017

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/28
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Certain 1,2,4-triazolo(4,3-b)pyridazines of formula ##STR1## including pharmaceutically acceptable salts thereof, wherein R.sub.1 -R.sub.8 are as defined in the disclosure, for the treatment, prophylaxis and/or inhibition of seizures, neurological disorders such as epilepsy and/or conditions in which there is neurological damage such as stroke, brain trauma, cerebral ischemia, head injuries and hemorrhage are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.